Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CTR20241591Phase 3Completed
A Phase 3 trial of Bairui granules in upper respiratory infection (URI), sponsored by Jiuhua Huayuan Pharmaceutical. Started May 2024; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on CTR20241591.